Clindamycin Hypersensitivity and Management in a Case with Invasive Group A Streptococcal Cellulitis Caused by Chickenpox

被引:0
|
作者
Durmus, Sevgi Yasar [1 ]
Tanir, Gonul [1 ]
Kaman, Ayse [1 ]
Akcan, Ozge Metin [2 ]
Demir, Merve [3 ]
机构
[1] Dr Sami Ulus Obstet & Gynecol Childrens Hlth & Di, Clin Pediat Infect Dis, Ankara, Turkey
[2] Necmettin Erbakan Univ, Dept Pediat Infect Dis, Sch Med, Konya, Turkey
[3] Dr Sami Ulus Obstet & Gynecol Childrens Hlth & Di, Clin Pediat, Ankara, Turkey
来源
JOURNAL OF PEDIATRIC INFECTION | 2019年 / 13卷 / 01期
关键词
Chickenpox; clindamycin; group A streptococcus; hypersensitivity; VARICELLA;
D O I
10.5578/ced.201906
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Chickenpox is commonly known as a benign exenthamatous disease of childhood that causes vesicular rashes. Symptomatic therapy is usually adequate for chickenpox but in some cases secondary bacterial infections constitute the most common cause of morbidity in children. Primer varicella is an important predisposing factor for invasive group A streptococcal infection. In the treatment of invasive group A streptococcal infection generally accepted therapeutic management includes early administration of penicillin in combination with clindamycin, intravenous immunoglobulins and early surgical intervention. In this report we describe a patient who developed clindamycin hypersensitivity during invasive group A streptococcal cellulitis management.
引用
收藏
页码:E32 / E34
页数:3
相关论文
共 50 条
  • [1] Management of invasive group A streptococcal infections
    Waddington, Claire S.
    Snelling, Thomas L.
    Carapetis, Jonathan R.
    [J]. JOURNAL OF INFECTION, 2014, 69 : S63 - S69
  • [2] Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
    Laho, Delphine
    Blumental, Sophie
    Botteaux, Anne
    Smeesters, Pierre R.
    [J]. FRONTIERS IN PEDIATRICS, 2021, 9
  • [3] Severe invasive β haemolytic group A streptococcal cellulitis and eyelid necrosis treated with linezolid
    Barry, J-S
    Burge, J. A.
    Byles, D. B.
    Morgan, M. S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (09) : 1204 - 1204
  • [4] Invasive group A streptococcal disease: Management and chemoprophylaxis
    Allen, U. D.
    Moore, D. L.
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2010, 21 (03): : 115 - 118
  • [5] Invasive group A streptococcal disease: Management and chemoprophylaxis
    Allen, U. D.
    Moore, D. L.
    [J]. PAEDIATRICS & CHILD HEALTH, 2010, 15 (05) : 295 - 298
  • [6] Invasive group A streptococcal disease: Management and chemoprophylaxis
    Moore, Dorothy L.
    Allen, Upton D.
    Mailman, Timothy
    [J]. PAEDIATRICS & CHILD HEALTH, 2019, 24 (02) : 128 - 128
  • [7] Management of severe invasive group A streptococcal infections
    Faye, A.
    Lorrot, M.
    Bidet, Ph.
    Bonacorsi, S.
    Cohen, R.
    [J]. ARCHIVES DE PEDIATRIE, 2014, 21 : S87 - S92
  • [8] Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections
    Carapetis, Jonathan R.
    Jacoby, Peter
    Carville, Kylie
    Ang, Seong-Jin Joel
    Curtis, Nigel
    Andrews, Ross
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (03) : 358 - 365
  • [9] Invasive Group A Streptococcal Disease Epidemiology, Pathogenesis and Management
    Steer, Andrew C.
    Lamagni, Theresa
    Curtis, Nigel
    Carapetis, Jonathan R.
    [J]. DRUGS, 2012, 72 (09) : 1213 - 1227
  • [10] Invasive group a streptococcal disease: Epidemiology, pathogenesis and management
    Steer A.C.
    Lamagni T.
    Curtis N.
    Carapetis J.R.
    [J]. Drugs, 2012, 72 (9) : 1213 - 1227